| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |